Results 231 to 240 of about 53,802 (245)

Challenges in ductal carcinoma in situ risk communication and decision‐making

Ca-A Cancer Journal for Clinicians, 2012
Ann H Partridge, Joann G Elmore, Debbie Saslow   +2 more
exaly  

Cancer statistics: Breast cancer in situ

Ca-A Cancer Journal for Clinicians, 2015
Elizabeth M Ward, Chun Chieh Lin, Ahmedin Jemal   +2 more
exaly  

The diagnosis and management of ductal carcinoma in-situ of the breast

Ca-A Cancer Journal for Clinicians, 2000
David P Winchester, Robert A Goldschmidt
exaly  

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

Annals of Oncology, 2017
Giancarlo Pruneri, Matteo Lazzeroni, Nicole Rotmensz   +2 more
exaly  

The Role of HER2/neu Overexpression/Amplification in the Progression of Ductal Carcinoma In Situ to Invasive Carcinoma of the Breast

Modern Pathology, 2002
F P O'Malley
exaly  

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial

Lancet, The, 2003
W D George, Jack Cuzick, Catherine Duggan   +2 more
exaly  

Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

Cancer, 1995
William D Dupont, Lowell W Rogers, Roy A Jensen   +2 more
exaly  

MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study

Lancet, The, 2007
Christiane K Kuhl, Simone Schrading, Eva Wardelmann   +2 more
exaly  

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry

Histopathology, 2006
Eisei Shin
exaly  

Ductal Carcinoma In Situ of the Breast

Annual Review of Medicine, 2000
Melvin J Silverstein
exaly